Personalizing Treatment with the Oncotype DX Colon Cancer Assay

How does the Oncotype DX Colon Cancer Assay help doctors personalize treatment?

The Oncotype DX Colon Cancer Assay is a molecular test. It is changing the way doctors treat different cancers. This test gets doctors critical information on the genetic makeup of your cancer. With this knowledge, doctors can predict how your cancer will grow and react to different treatments. Doctors take this information and create a personalized treatment plan for their patients. Dr. Mark Kozloff explains how in this video.

To learn more about the Oncotype DX Colon Cancer Assay watch “Oncotype DX Colon Cancer Treatment Decisions” with Dr. Mark Kozloff.

Video Transcripts

Mark F. Kozloff, MD: I have been taking care of patients now for over 30 years but really has made a difference to me in the last several years is the information we can get that really tells us more about a person’s individualized cancer doing biomarkers, seeing where treatments can be helpful to some, not helpful to others where I can do a better way of giving a person a prognosis. I think this personalized medicine is just not a word, it is really something that we have to do now and in the future and it has really made a difference to me over the last several years comparing to what I did 30 years ago.

• Bio
• Latest Posts

Mark Kozloff

Dr. Mark Kozloff is board certified in Internal Medicine. He earned his degree in medicine from the University of Michigan Medical School and completed his residency at Michael Reese Hospital in Chicago. Dr. Kozloff works on a multidisciplinary team of experts in the Center for Gastrointestinal Oncology where he specializes in the treatment of colorectal malignancies.

Latest posts by Mark Kozloff (see all)

• Personalizing Treatment with the Oncotype DX Colon Cancer Assay - January 1, 1970
• Passing Knowledge on to Colon Cancer Doctors - January 1, 1970
• Ordering the Colon Cancer Assay - January 1, 1970